Similar Articles
Causes of Death in Multiple Sclerosis: Cross-sectional Analysis of 16 Years Period
Serkan ÖZAKBAŞ, Burak PAKÖZ, İhsan Şükrü ŞENGÜN, Barış BAKLAN, Göksemin DEMİR, Bülent ÜNLÜ, Zuhal BAHAR, Egemen İDİMAN
A Case of Mu/tiple Sclerosis Presenting As Unilateral Papillitis
Nurgül YILMAZ, Ebru ÖZAY, Funda AÇIKGÖZ, Nursel AYDIN
Multimodal Evoked Potentialsin Follow-up of Treatment of Multiple Sclerosis With lnterferon Beta-1 a
Serkan ÖZAKBAŞ, Raif ÇAKMUR, Vesile ÖZTÜRK, Egemen İDİMAN, Fethi İDİMAN
lnterferon Beta-1b In TheTreatment Of Relapsing Remitting Multiple Sclerosis:Clinical and Magnetic Resonance lmaging Results
Serkan ÖZAKBAŞ, Egemen İDİMAN, Handan ÇAKMAKÇI, İlhami KOVANLIKAYA
Cytokines in Multiple Sclerosis
A. ALTINTAŞ, O. KANTARCI, S. SAİP, A. SİVA, S. ÖZTUZCU, N. HEKİM, P. BOZKURT
Beta lnterferon-lA Treatment in Multipl Sclerosis and Cognitive Functions
E. İDİMAN, G. G. YENER, G. AKDAL, S. ÖZAKBAŞ
The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.
D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN
Clinical Scales for Multiple Sclerosis
Kadriye ARMUTLU, Rana KARABUDAK
HLA Tissue Antigens in Multiple Sclerosis
Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL
Serum Vitamin B12 and Folate Levels in Multiple Sclerosis
H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER
Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.
Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM
THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS
Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA
Intradural Extension of Idiopatbic Orbital Inflammation (Orbital Pseudotumor): A CaseReport.
Ayşe SAĞDUYU ÖZKAYA, Egemen VARDARLI, Önder AKYÜREKLİ
Multiple Sclerosis Cases with Atypical Signs
Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY
Myalgia-arthralgia and Associated Factors in Patients with COVID-19
Fettah Eren, Bengü Özkan, Ayşegül Demir
DOI: 10.4274/tnd.2021.85453
Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population
Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy
DOI: 10.4274/tnd.2021.63444
Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Rana KARABUDAK
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU